G.E.R.N. Tissue Replacement, Regeneration & Neogenesis, Department of Orthopedics and Trauma Surgery, Medical Center- Albert-Ludwigs-University of Freiburg, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany.
Institute of Microbiology and Hygiene, Faculty of Medicine, Medical Center Albert-Ludwigs-University of Freiburg, Hermann- Herder-Straße 11, 79104, Freiburg, Germany.
BMC Biotechnol. 2024 Jun 3;24(1):38. doi: 10.1186/s12896-024-00863-4.
BACKGROUND: Antibiotic-containing carrier systems are one option that offers the advantage of releasing active ingredients over a longer period of time. In vitro sustained drug release from a carrier system consisting of microporous β-TCP ceramic and alginate has been reported in previous works. Alginate dialdehyde (ADA) gelatin gel showed both better mechanical properties when loaded into a β-TCP ceramic and higher biodegradability than pure alginate. METHODS: Dual release of daptomycin and BMP-2 was measured on days 1, 2, 3, 6, 9, 14, 21, and 28 by HPLC and ELISA. After release, the microbial efficacy of the daptomycin was verified and the biocompatibility of the composite was tested in cell culture. RESULTS: Daptomycin and the model compound FITC protein A (n = 30) were released from the composite over 28 days. A Daptomycin release above the minimum inhibitory concentration (MIC) by day 9 and a burst release of 71.7 ± 5.9% were observed in the loaded ceramics. Low concentrations of BMP-2 were released from the loaded ceramics over 28 days.
背景:含抗生素载体系统是一种提供活性成分更长时间释放优势的选择。先前的研究报道了由微孔β-TCP 陶瓷和藻酸盐组成的载体系统中抗生素的体外持续药物释放。与纯藻酸盐相比,ADA 明胶凝胶负载到β-TCP 陶瓷中时显示出更好的机械性能和更高的生物降解性。 方法:通过 HPLC 和 ELISA 在第 1、2、3、6、9、14、21 和 28 天测量达托霉素和 BMP-2 的双重释放。释放后,验证达托霉素的微生物功效,并在细胞培养中测试复合材料的生物相容性。 结果:达托霉素和模型化合物 FITC 蛋白 A(n=30)在 28 天内从复合材料中释放出来。在负载陶瓷中,第 9 天观察到达托霉素释放量超过最小抑菌浓度(MIC),并出现 71.7±5.9%的爆发式释放。负载陶瓷中持续释放低浓度的 BMP-2。
BMC Biotechnol. 2024-6-3
Clin Orthop Relat Res. 2025-3-1
BMC Biotechnol. 2024-5-15
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2021-11-15
J Biomed Mater Res B Appl Biomater. 2025-7
Infect Immun. 2025-6-10
ACS Appl Mater Interfaces. 2025-7-16
Biomedicines. 2022-12-13
Acta Biomater. 2022-5
Microorganisms. 2020-11-10
Infect Dis Clin North Am. 2017-6
BMC Biotechnol. 2016-5-20